Consun Pharmaceutical Group (HKSE:01681) Change In Inventory : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Change In Inventory?

Consun Pharmaceutical Group's change in inventory for the quarter that ended in Dec. 2023 was HK$0 Mil. It means Consun Pharmaceutical Group's inventory stayed the same from Jun. 2023 to Dec. 2023 .

Consun Pharmaceutical Group's change in inventory for the fiscal year that ended in Dec. 2023 was HK$-112 Mil. It means Consun Pharmaceutical Group's inventory increased by HK$112 Mil from Dec. 2022 to Dec. 2023 .

Consun Pharmaceutical Group's Total Inventories for the quarter that ended in Dec. 2023 was HK$402 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Consun Pharmaceutical Group's Days Inventory for the quarter that ended in Dec. 2023 was 168.33.

Inventory Turnover measures how fast the company turns over its inventory within a year. Consun Pharmaceutical Group's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.08.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Consun Pharmaceutical Group's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.24.

Consun Pharmaceutical Group Change In Inventory Historical Data

The historical data trend for Consun Pharmaceutical Group's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Change In Inventory Chart

Consun Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-4.48

-33.79

-48.43

-61.31

-111.59

Consun Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Consun Pharmaceutical Group Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Consun Pharmaceutical Group (HKSE:01681) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Consun Pharmaceutical Group's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	388.5925	/	421.295	*	365 / 2
	=	168.33

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Consun Pharmaceutical Group's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	421.295	/	388.5925
	=	1.08

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Consun Pharmaceutical Group's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	388.5925	/	1608.332
	=	0.24

Consun Pharmaceutical Group Change In Inventory Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Consun Pharmaceutical Group (HKSE:01681) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Change In Inventory

Traded in Other Exchanges

C1P:Germany

Address

71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN

Website

https://www.chinaconsun.com

Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

Executives

An Yubao	2101 Beneficial owner
Li Qian	2101 Beneficial owner
Central Success Developments Limited	2101 Beneficial owner
Aali Resources Limited	2201 Interest of corporation controlled by you
Bos Trustee Limited	2301 Trustee
Zhang Lihua	2202 Interest of your spouse
An Meng	2101 Beneficial owner
Double Grace International Limited	2101 Beneficial owner
Bos Trustee Limited As Trustee	2201 Interest of corporation controlled by you

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines